ETON
Eton Pharmaceuticals, Inc.
Latest Form 4:Sale$3.0MbyMAIER PAUL V (Director) · filed Aug 31, 2026
Eton Pharmaceuticals, Inc. (ETON) has 20 SEC Form 4 filings (50 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Aug 31, 2026.
The most active filer is Chief Business Officer Krempa David with 4 filings. Insiders have net sold $25.2M over the trailing 6 months.
- Industry:Drug Manufacturers - Specialty & Generic
- CEO:Sean E. Brynjelsen
- Employees:44
- HQ:Deer Park, IL, US
- IPO:2018-11-14
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$25.2M
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Market Cap
$1.7B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Director | Sale | 50,000 | $3.0M | Aug 31 | SEC ↗ | |
| Chief Business Officer | Sale | 25,000 | $1.6M | Aug 24 | SEC ↗ | |
| President & CEO | Sale | 8,978 | $562K | Aug 20 | SEC ↗ | |
| President & CEO | Sale | 91,022 | $5.5M | Aug 20 | SEC ↗ | |
| 10% Owner | Sale | 28,315 | $1.1M | Jul 17 | SEC ↗ | |
| 10% Owner | Sale | 90,000 | $3.4M | Jul 7 | SEC ↗ | |
| 10% Owner | Sale | 10,000 | $380K | Jul 7 | SEC ↗ | |
| 10% Owner | Sale | 26,685 | $1.0M | Jul 7 | SEC ↗ | |
Adams Jennifer McKieFirst filing | Director | Sale | 50,000 | $1.6M | Jun 17 | SEC ↗ |
BRYNJELSEN SEANFirst filing | President & CEO | Sale | 120,000 | $3.8M | May 29 | SEC ↗ |
Krempa DavidFirst filing | Chief Business Officer | Sale | 42,797 | $1.4M | May 27 | SEC ↗ |
Krempa DavidFirst filing | Chief Business Officer | Sale | 37,524 | $1.2M | May 27 | SEC ↗ |
Krempa DavidFirst filing | Chief Business Officer | Sale | 19,679 | $619K | May 27 | SEC ↗ |
Related companies
Eton Pharmaceuticals, Inc. is in the Healthcare sector.